Focus on the development of the company to better respond to Customers' expectations
Chief Executive Officer
Peter Burema, Chief Executive Officer, joined NextPharma in June 2014. He has more than 30 years of industry experience, including leadership roles in big pharma, generic drug manufacturing and contract manufacturing. Most recently, Peter served as CEO of Acino, a Swiss-based pharmaceutical company that he led for four years. Prior to that, Peter's experience includes eight years with Ranbaxy Europe Ltd, where he led their Global Pharmaceuticals Business and thirteen years at Bayer. Peter graduated from the St. Olof Business School in the Netherlands.
Chief Mergers and Acquisitions Officer
Alan Dodsworth, Chief Mergers and Acquisitions Officer, joined NextPharma in 2004. Previously, Alan held the positions of Chief Financial Officer (2014-2018) and Executive VP Corporate Development. Prior to joining NextPharma, Alan spent nine years at Ernst & Young, where he was an Assistant Director specialising in corporate finance and transaction support services, leading cross-functional and international teams. Alan is a Chartered Accountant and holds a degree in Economics and History.
Chief Financial Officer
Mark Hawkins, Chief Financial Officer, joined NextPharma in 2009. Previously, Mark held the positions of Director Controlling and Group Financial Controller with NextPharma. Prior to joining NextPharma, he spent ten years at PricewaterhouseCoopers (London and South East UK), where he worked in Assurance Services working with businesses from a broad range of sectors. Mark is a Chartered Accountant and is an Economics graduate from Glasgow University.
Chief Operating Officer
Eric Schmidhäuser, Chief Operating Officer, joined NextPharma in July 2016. Eric brings with him over 20 years' experience in the pharmaceutical and automotive industries, with his most recent role being Managing Director for Corden Pharma GmbH. Prior to this, Eric was with Catalent Pharma Solutions for more than 6 years as Managing Director for Catalent Germany Schorndorf GmbH. Eric has held several international management positions in different industries. With this breadth of experience Eric is well placed to support our company growth strategy.
Chief Commercial Officer
Pierre Delavaud, Chief Commercial Officer, joined NextPharma in September 2012 with a strong track record in sales, business development and marketing within the pharmaceutical industry. Prior to joining NextPharma, Pierre held executive sales and business development positions at SkyePharma and spent fourteen years with the Catalent group (and former companies), where he held various senior positions, including Vice President Sales and Business Development Global Pharmaceutical Softgels, Vice President Sales and Marketing Pharmaceutical Technologies and Services Europe, as well as General Manager of a manufacturing site. Pierre holds a PhD in Pharmacy.
Chief Scientific Officer
Kathrin Bartscher, Chief Scientific Officer, joined NextPharma in 2006. She started her career as a project manager in formulation development and over the years has held various positions in the area of product development. In September 2016 she took over the responsibility for the global NextPharma development activities.
Since 2014 she is board member of the International Association for Pharmaceutical Technology (APV e.V.) and from 2014 to 2023 she held the position of treasurer of APV. Since 2018 she is an external lecturer for the Master of Industrial Pharmacy program at the Heinrich-Heine-University, Duesseldorf. Kathrin holds a PhD in Pharmaceutical Technology.
Chief Information Officer
Joel Fidalgo, Chief Information Officer, joined NextPharma in March 2020 with the focus to digitize our Business Processes across all NextPharma sites to support our future growth. Before joining NextPharma, Joel spent 6,5 years at West Pharmaceutical Services in different global IT Leadership positions and before worked over 6 years as IT Management Consultant for international customers across various industries. Joel studied electrical Engineering with focus on Information Technology at the University of Applied Science in Aachen.
Global Head of HR
Angelique Löber, Global Head of HR, joined NextPharma in 2011 and is member in our Extended Exec since 2018. Previously, Angelique held the positions of Head of HR Germany and HR Manager with NextPharma. Prior to joining NextPharma, she spent several years at MRI Network as HR Consultant and at one of Germany`s largest cinema groups CineStar, where she worked in Human Resources. Angelique holds a degree in Economics and Labor Law.
Vice President Quality
Andreas Henkel, Vice President Quality, joined NextPharma in February 2018. Andreas brings with him 20 years of experience in the pharmaceutical industry. Prior to joining NextPharma, he spent in total 15 years at F. Hoffman-La Roche AG (Basle, Switzerland) and Berlin-Chemie AG (Germany) where he held several local and international management positions in Quality and Technical Operations. Andreas holds a Ph.D. in Biophysical Analytics from Max-Planck-Institute for Molecular Physiology.